These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33441293)

  • 21. Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy.
    Jacob JM; Ferry EK; Gay LM; Elvin JA; Vergilio JA; Ramkissoon S; Severson E; Necchi A; Killian JK; Ali SM; Schrock AB; Liu NW; Chung J; Miller VA; Stephens PJ; Welsh A; Corona RJ; Ross JS; Bratslavsky G
    J Urol; 2019 Mar; 201(3):541-548. PubMed ID: 30291913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy.
    Chen YP; Wang YQ; Lv JW; Li YQ; Chua MLK; Le QT; Lee N; Colevas AD; Seiwert T; Hayes DN; Riaz N; Vermorken JB; O'Sullivan B; He QM; Yang XJ; Tang LL; Mao YP; Sun Y; Liu N; Ma J
    Ann Oncol; 2019 Jan; 30(1):68-75. PubMed ID: 30407504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CSN1 Somatic Mutations in Penile Squamous Cell Carcinoma.
    Feber A; Worth DC; Chakravarthy A; de Winter P; Shah K; Arya M; Saqib M; Nigam R; Malone PR; Tan WS; Rodney S; Freeman A; Jameson C; Wilson GA; Powles T; Beck S; Fenton T; Sharp TV; Muneer A; Kelly JD
    Cancer Res; 2016 Aug; 76(16):4720-4727. PubMed ID: 27325650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.
    Sun Y; Qin S; Wang S; Pang J; Ou Q; Liang W; Zhong H
    J Pathol Clin Res; 2024 May; 10(3):e12375. PubMed ID: 38661052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus infection affects treatment outcomes and the immune microenvironment in patients with advanced penile squamous cell carcinoma receiving programmed cell death protein 1 inhibitor-based combination therapy.
    Wei L; Li Z; Guo S; Ma H; Shi Y; An X; Huang K; Xiong L; Xue T; Zhang Z; Yao K; Luo J; Han H
    Cancer; 2024 May; 130(9):1650-1662. PubMed ID: 38157276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
    Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
    Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation Between the Evolution of Somatic Alterations During Lymphatic Metastasis and Clinical Outcome in Penile Squamous Cell Carcinoma.
    Cao J; Yang CH; Han WQ; Xie Y; Liu ZZ; Jiang SS
    Front Oncol; 2021; 11():641869. PubMed ID: 34150614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DaPeCa5 - obesity at the time of diagnosis does not predict poor cancer-specific survival in patients with penile squamous cell carcinoma - a Danish National study.
    Jakobsen JK; Kortsen D; Jensen JB
    Scand J Urol; 2020 Oct; 54(5):420-425. PubMed ID: 32772767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of Her-2 in penile squamous cell carcinoma progression and cisplatin chemoresistance and potential for antibody-drug conjugate-based therapy.
    Tan X; Wang Y; Wu Z; Zhou Q; Tang Y; Liu Z; Yuan G; Luo S; Zou Y; Guo S; Han N; Yao K
    Eur J Cancer; 2023 Nov; 194():113360. PubMed ID: 37862796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-modality analysis supports APOBEC as a major source of mutations in head and neck squamous cell carcinoma.
    Faden DL; Thomas S; Cantalupo PG; Agrawal N; Myers J; DeRisi J
    Oral Oncol; 2017 Nov; 74():8-14. PubMed ID: 29103756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of histologic subtype, p16(INK4a) expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma.
    Steinestel J; Al Ghazal A; Arndt A; Schnoeller TJ; Schrader AJ; Moeller P; Steinestel K
    BMC Cancer; 2015 Apr; 15():220. PubMed ID: 25885064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational Analysis of 472 Urothelial Carcinoma Across Grades and Anatomic Sites.
    Nassar AH; Umeton R; Kim J; Lundgren K; Harshman L; Van Allen EM; Preston M; Dong F; Bellmunt J; Mouw KW; Choueiri TK; Sonpavde G; Kwiatkowski DJ
    Clin Cancer Res; 2019 Apr; 25(8):2458-2470. PubMed ID: 30593515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 34. New Insights into the Molecular Profile of Penile Squamous Cell Carcinoma.
    McGregor BA; Sonpavde GP
    Clin Cancer Res; 2021 May; 27(9):2375-2377. PubMed ID: 33653819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulation of indoleamine 2,3-dioxygenase 1 (IDO1) expression and catalytic activity is associated with immunosuppression and poor prognosis in penile squamous cell carcinoma patients.
    Zhou QH; Han H; Lu JB; Liu TY; Huang KB; Deng CZ; Li ZS; Chen JP; Yao K; Qin ZK; Liu ZW; Li YH; Guo SJ; Ye YL; Zhou FJ; Liu RY
    Cancer Commun (Lond); 2020 Jan; 40(1):3-15. PubMed ID: 32125093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models.
    Facompre ND; Rajagopalan P; Sahu V; Pearson AT; Montone KT; James CD; Gleber-Netto FO; Weinstein GS; Jalaly J; Lin A; Rustgi AK; Nakagawa H; Califano JA; Pickering CR; White EA; Windle BE; Morgan IM; Cohen RB; Gimotty PA; Basu D
    Int J Cancer; 2020 Dec; 147(11):3236-3249. PubMed ID: 32478869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of ID1 promotes tumor progression in penile squamous cell carcinoma.
    Hu X; Chen M; Li Y; Wang Y; Wen S; Jun F
    Oncol Rep; 2019 Feb; 41(2):1091-1100. PubMed ID: 30535485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SPP1 is associated with adverse prognosis and predicts immunotherapy efficacy in penile cancer.
    Zou Y; Tan X; Yuan G; Tang Y; Wang Y; Yang C; Luo S; Wu Z; Yao K
    Hum Genomics; 2023 Dec; 17(1):116. PubMed ID: 38111044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TP53-Associated Ion Channel Genes Serve as Prognostic Predictor and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma.
    Sun J; Yu X; Xue L; Li S; Li J; Tong D; Du Y
    Technol Cancer Res Treat; 2020; 19():1533033820972344. PubMed ID: 33243093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PI3K pathway mutation predicts an activated immune microenvironment and better immunotherapeutic efficacy in head and neck squamous cell carcinoma.
    Wang L; Chen K; Weng S; Xu H; Ren Y; Cheng Q; Luo P; Zhang J; Liu Z; Han X
    World J Surg Oncol; 2023 Mar; 21(1):72. PubMed ID: 36864522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.